Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 18.5B | 16.2B | 14.9B | 11.3B |
Cost of revenue | 12.4B | 10.9B | 10.4B | 6.8B |
Gross profit | 6.1B | 5.3B | 4.5B | 4.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | -48M |
Other operating expenses | 2.5B | 2.7B | 2.3B | 2.3B |
Operating income | 3.7B | 2.6B | 2.2B | 2.3B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 1.3B | 1.1B | 1.3B | 1.1B |
Other income expense | 849M | -670M | 855M | 1.5B |
Pretax income | 3.2B | 849M | 1.8B | 2.7B |
Tax provision | 697M | 231M | 312M | 739M |
Net income | 2.5B | 618M | 1.4B | 2.0B |
Basic EPS | — | — | — | — |
Diluted EPS | — | — | — | — |
Basic average shares | — | — | — | — |
Diluted average shares | — | — | — | — |
EBITDA | 6.1B | 4.9B | 4.2B | 4.2B |
Net income from continuing op. | 2.5B | 618M | 1.4B | 2.0B |
Minority interests | -126M | -23M | -56M | -58M |
Preferred stock dividends | — | — | — | — |